MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Efficacy of levodopa/carbidopa/entacapone replacement of levodopa/dopa decarboxylase inhibitors in treatment of Chinese Parkinson’s disease patients with wearing-off: a multicenter, randomized controlled, open label study

    CY. Yu, WG. Liu, AP. Gong, LH. Shen, H. Huang, Y. Zhao, CF. Liu (nanjing, China)

    Objective: This study aimed to investigate the efficacy and safety comparison between LCE and Pramexol in Chinese PD patients with the wearing-off phenomenon. Background: Wearing…
  • 2023 International Congress

    Analysis of the therapeutic potential of IkT-148009 in Parkinson’s disease

    M. Werner, R. Rush, T. Kelly, S. Singh, S. Kruger, C. Olanow, A. Mcgarry (Atlanta, USA)

    Objective: To evaluate the therapeutic potential of the selective, brain penetrant c-Abl inhibitor IkT-148009 in mouse models of progressive PD and the safety and tolerability…
  • 2023 International Congress

    Validating wearable sensors as an assessment tool for Parkinson’s Disease

    K. Silis, N. Kieran, N. Shawki, S. Madarshahian, M. Serruya, T. Liang (Philadelphia, USA)

    Objective: The objective of our pilot study was to assess the feasibility of using a portable accelerometer system to accurately identify motor findings in patients…
  • 2023 International Congress

    Cognitive function in Parkinson’s disease: associations with perivascular space in basal ganglia

    L. Luo, L. Li, Y. Yin, R. Ren, Y. Yang (Kunming, China)

    Objective: This study investigated the association of enlarged perivascular space (EPVS) and white matter hyperintensity (WMH) with cognitive impairment in Parkinson's disease (PD). Background: Cognitive…
  • 2023 International Congress

    Long-term effects of a mobile technology-based brisk walking program on Parkinsonian symptoms in Parkinson’s disease – a randomized controlled trial

    MKY. Mak, ISK. Wong-Yu (Hong Kong SAR, China)

    Objective: To evaluate the effectiveness of a 6-month mobile technology-based brisk walking program on motor and non-motor symptoms and self-perceived ability in people with Parkinson’s…
  • 2023 International Congress

    Inferring Rigidity Scores in MDS-UPDRS Motor Assessment from Other Items

    F. Duque Quiceno, Y. Dushin, G. Sarapata, S. Komarov, A. Matveev, J. O'Keeffe (London, United Kingdom)

    Objective: This study aimed to explore the possibility of inferring rigidity scores in MDS-UPDRS assessments from other items to enhance the accuracy of clinical evaluations…
  • 2023 International Congress

    Impact of endpoint selection on sample size calculations for disease-modifying clinical trials in Parkinson’s disease patients with GBA1 mutations

    M. Fonseca, G. Castilla-Fernández, J. Liu, J. Holenz, N. Mendonça, D. Simon (Porto, Portugal)

    Objective: To assess clinical trial sample size estimations under variable simulated scenarios for Parkinson’s disease (PD) patients with mutations in the β-glucocerebrosidade gene (GBA1). Background:…
  • 2023 International Congress

    Parkinson’s disease and human gut microbiota in an Egyptian population: a pilot study

    S. Hashish, M. Hirose, A. Moustafa, A. Shalash, S. Ibrahim, M. Salama (Cairo, Egypt)

    Objective: The main objective of our research is to decipher the association between the gut microbiota and Parkinson's disease in an Egyptian cohort. Background: Parkinson’s…
  • 2023 International Congress

    PD.ai – Detection of Parkinson’s Disease with gait-based biomarkers using AI techniques

    SJS. Rajasekar, A. Stezin (Melmaruvathur, India)

    Objective: This study evaluated the utility of Artificial Intelligence (AI) in detection of patients with Parkinson’s disease from stride dynamics. Background: Parkinson’s Disease (PD) is…
  • 2023 International Congress

    Effects of cerebellar cTBS on motor symptoms in Huntington’s disease: a feasibility and pilot study

    JF. Martin Rodriguez, M. Gomez Crespo, FJ. Gómez Campos, AM. Castellano-Gerrero, V. Villarreal, FJ. Palomar Simón, P. Porcacchia, F. Carrillo, S. Jesús, P. Mir (Sevilla, Spain)

    Objective: To evaluate the feasibility and preliminary clinical effects of a single session of cerebellar cTBS in patients with Huntington's disease (HD) with mild-moderate motor…
  • « Previous Page
  • 1
  • …
  • 153
  • 154
  • 155
  • 156
  • 157
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley